Home|Journals|Articles by Year|Audio Abstracts

Case Report

Clinical management of foot rot in goats: A case report of lameness

Asinamai Athliamai Bitrus, Yusuf Abba, Faez Firdaus Abdullah Jesse, Lim Mei Yi, Robinn Teoh, Muhammad Abubakar Sadiq, Eric Lim Teik Chung, Mohd Azmi Mohd Lila, Abd Wahid Haron.


Objective: Foot rot is one of the most important causes of lameness and economic losses in sheep and goats world-wide. This case report described the clinical management of lameness due to foot rot in two female Boer goats aging 4-year both from two different farms in Selangor, Malaysia.
Materials and methods: The goats were presented with the complaint of non-weight bearing lameness of the right forelimbs. The hoof was broken and the interdigital space was filled with dirt and exuding a foul smelling odor.
Results: On clinical examination, the goats were looking as dull and isolated with body condition scores of 2.5/5 (case 1) and 3/5 (case 2), respectively. The goats had a rectal temperature of 38.8°C and 40.4°C, pulse rate of 80 and 100 beats per minutes, and respiratory rate of 44 and 24 cycles per minute, respectively. Blood sample was collected for complete blood count and serum biochemistry from case 1 only. The hoof was thoroughly washed and disinfected. Parenteral administrations of Flunixin meglumine (dosed at 2.2 mg/kg bwt, IM) thrice daily and Oxytetracycline (dosed at 20 mg/kg bwt, IM case 1) once and Sulfadiazine+trimethoprim (dosed at 1 mL/16 kg bwt, IM case 2) for 3 days. Topical oxytetracycline was applied to the area for 5 days.
Conclusion: The prognosis was very good as there was a significant improvement in the hoof injury of both animals. The goats were recovered after 7 days of treatment.

Key words: Boer goat; Clinical management; Foot rot; Lameness

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.